Fishel said that she did not undergo surgeries or chemotherapy outside of her radiation treatment, and that she will now start Tamoxifen, a medication that can help reduce breast cancer recurrences, according to the National Cancer Institute. She also said ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects of these treatments include osteoporosis,

Niagara men's basketball kicked off Suits and Sneakers week, in which college basketball coaches wear suits and sneakers on the sidelines and programs across the nation raise money for cancer research and awareness.

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

According to the World Health Organization (WHO), in 2022, there were 2.3 million women diagnosed with breast cancer and 670 000 deaths globally.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result provides more accurate estimates about that patient’s breast cancer prognosis and their potential benefit from chemotherapy than either the Recurrence Score result or clinical factors alone.

Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

Scientists at a university in the UK are in the midst of creating a breakthrough vaccine that could stop cancer in its tracks.

A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly shrink large ones in mice with a single dose. This innovative approach targets estrogen receptor-positive cancers more selectively,